Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.81 |
| ▸ | CASP2 | P42575 | 1/20 | 0.72 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.67 |
| ▸ | NAAA | Q02083 | 1/20 | 0.67 |
| ▸ | FAAH | O00519 | 3/20 | 0.60 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.55 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5436704 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL10866304 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL2944555 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL3708747 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL8210316 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL1901704 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL10866272 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL8197425 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL4501660 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA | |
| SCHEMBL8209020 | 1.00 | MEN1 (0.81) | MEN1KMT2ACASP2EPHX1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2603083-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES | Microbion Corporation (US) | 2013-06-19 | — | — | EP | claimed |
| EP-2536406-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES | Microbion Corporation (US) | 2012-12-26 | — | — | EP | claimed |
| WO-2012021754-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES | MICROBION CORPORATION (US) | 2012-02-16 | — | — | WO | claimed |
| WO-2011097347-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES | MICROBION CORPORATION (US) | 2011-08-11 | — | — | WO | claimed |
| CN-118558261-A | Microcapsule for alkali metal battery, preparation method of microcapsule, alkali metal battery and electric equipment | 重庆弗迪电池研究院有限公司 | 2024-08-30 | — | — | CN | disclosed |
| US-20240025863-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | 2024-01-25 | — | — | US | disclosed |
| WO-2023133260-A2 | CHEMICAL TARGETING SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4 (SMARCA4) AND USE IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20230218765-A1 | SMALL MOLECULE DEGRADERS OF SHP2 PROTEIN | UNIV MICHIGAN REGENTS (US) | 2023-07-13 | — | — | US | disclosed |
| EP-3523311-B1 | SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022140554-A1 | SMALL MOLECULE DEGRADERS OF PHOSPHATIDYLINOSITOL-5-PHOSPHATE 4-KINASE TYPE 2 AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022091373-A1 | LIGHT EMITTING ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND METHOD FOR PRODUCING LIGHT EMITTING ELEMENT | シャープ株式会社 | 2022-05-05 | — | — | WO | disclosed |
| EP-3461835-A1 | CYCLOSPORINE ANALOGUE MOLECULES MODIFIED AT AMINO ACID 1 AND 3 | ContraVir Pharmaceuticals, Inc. (US) | 2019-04-03 | — | — | EP | disclosed |
| EP-2603083-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES | Microbion Corporation (US) | 2013-06-19 | — | — | EP | disclosed |
| US-20120189627-A1 | Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses | HEAVNER GEORGE (US) | 2012-07-26 | — | — | US | disclosed |
| WO-2012021754-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES | MICROBION CORPORATION (US) | 2012-02-16 | — | — | WO | disclosed |
| EP-2393491-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS | Microbion Corporation (US) | 2011-12-14 | — | — | EP | disclosed |
| EP-2348014-A1 | Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions | International Flavors & Fragrances Inc. (US) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010091124-A2 | BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS | MICROBION CORPORATION (US) | 2010-08-12 | — | — | WO | disclosed |
| EP-2147298-A1 | DETECTION OF CANCER MARKERS | Polytechnic University (US) | 2010-01-27 | — | — | EP | disclosed |
| WO-2008134511-A1 | DETECTION OF CANCER MARKERS | POLYTECHNIC UNIVERSITY (US) | 2008-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120189627-A1 | Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses | GLP1R, IAPP, GCG | MEN1 201/4885KMT2A 2042/4885CASP2 3067/4885 |
| US-20230218765-A1 | SMALL MOLECULE DEGRADERS OF SHP2 PROTEIN | PTPN1, PTPRS, PPM1D | MEN1 1432/4885KMT2A 675/4885CASP2 4306/4885 |
| US-20240025863-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | SOS1, SOS2, SOST | MEN1 453/4885KMT2A 3570/4885CASP2 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.